Bristol-Myers, Dana-Farber Settle Cancer IP Dispute
Bristol-Myers Squibb Co. and the Dana-Farber Cancer Institute have resolved a dispute in Massachusetts federal court over licensing revenue for six groundbreaking immunology patents, according to a Thursday court filing....To view the full article, register now.
Already a subscriber? Click here to view full article